Cancer is the second-leading cause of death in the United States, accounting for over 613,000 fatalities in 2023, per the Centers for Disease Control. But the field of cancer vaccines, which can be ...
ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Our mission is to help overcome challenges with innovative tools and solutions from discovery to the ...
RAPTER aims to identify the most effective vaccine strategy to help protect the population from pandemics, such as the COVID-19 pandemic. Shown here, a PNNL researcher performs a test to detect the ...
Vaccine development is traditionally driven by financial return opportunities for investors, disease outbreaks, and a specific focus on emerging diseases. However, a new systematic, transparent, and ...
The coronavirus has ground social, economic, and educational exchanges to a halt around the world. For now, public health officials are relying on tools like social distancing to minimize the harm of ...
Invivyd, Inc. has submitted a Citizen Petition to the FDA advocating for a new approach to the development of COVID-19 vaccines and monoclonal antibodies (mAbs) to restore public trust in health ...
Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...
A new thermostable vaccine that does not require refrigeration has shown promising early results in a human trial. If successful, the technology could simplify vaccine delivery worldwide and ...
Senior Manufacturing Science Associate Diane Morgan performs an analysis of plasmid DNA at Vernal Biosciences in Colchester on Tuesday, Aug. 12. Photo by Glenn Russell/VTDigger U.S. Health and Human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results